breast cancer
Conditions
Interventions
Treatment Group:Chuangling solution
Control group:Dilute iodine volts solution
Sponsors
Wang Jiangtao
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Have a clear understanding of the informed consent and signed a voluntary participation test.
Exclusion criteria
Exclusion criteria: 1. With severe complications such as infection and hemorrhage; 2. With history of other malignancies; 3. Patients who use steroids and other drugs to inhibit inflammation, or who are not cooperative, or who have a history of mental illness, or to participate in other clinical trials of drugs will be discontinued.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin flap temperature;Skin flap color;Color of drainage;Characteristics of drainage;Serum tumor necrosis factor-a; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum interleukin 2;Serum interleukin 6;Serum interleukin 8;Serum tumor necrosis factor-a;Serum C-reactive protein;Interleukin 2 in drainage;Interleukin 6 in drainage;Interleukin 8 in drainage;tumor necrosis factor-a in drainage;C-reactive protein in drainage; | — |
Countries
China
Contacts
Public ContactWang Jiangtao
Jiangsu Province Hospital of Traditional Chinese Medicine
Outcome results
None listed